Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) SHH
39.01
-0.38(-0.96%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
39.01
-0.38(-0.96%)
Currency In CNY
| Market Cap | 35.1B |
| Enterprise Value | 34.14B |
| P/E Ratio | 13.78 |
| PEG Ratio | -7.94 |
| Price/Sales Ratio | 4.44 |
| Price/Book Ratio | 3.99 |
| Enterprise/Revenue | 4.28 |
| Enterprise/EBITDA | 21.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.44 |
| Operating Margin | 0.49 |
| Return On Assets | 0.21 |
| Return On Equity | 0.27 |
| Revenue | 4.92B |
| Revenue/Share | 6.46 |
| Gross Profit | 3.64B |
| EBITDA | 2.61B |
| Net Income | 2.13B |
| Diluted EPS | 2.77 |
| Total Cash | 1.77B |
| Total Cash/Share | 2.3 |
| Total Debt | 57.84M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.16 |
| Book Value Per Share | 9.77 |
| 52-Week Change | 12.75 |
| 52-Week High | 50.97 |
| 52-Week Low | 31.68 |
| Moving Average 50 Days | 41.31 |
| Moving Average 200 Days | 44.05 |
| Average Volume | 4.1M |
| Shares Outstanding | 567.09M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 3.73 |
| Trailing Annual Dividend Yield | 9.56 |
| Payout Ratio | 0.86 |
| Last Split Factor | 2:1 |
| Last Split Date | July 05, 2010 |